G-CSF mimetics

Patent Number: 6346531

This patent provides compositions of matter that are useful for stimulating the receptor for granulocyte colony stimulating factor. The fact that G-CSF was the first drug introduced that acted on the level of stem cells suggests that this is an important area for drug development.

This patent may be useful not only for stimulation of neutrophil function, but also for increasing stem cell activity for treatment of stroke or myocardial infarction.

View this patent on the USPTO website.